9-110800369-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_005592.4(MUSK):​c.1991A>G​(p.Asn664Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.011 in 1,613,820 control chromosomes in the GnomAD database, including 162 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0081 ( 13 hom., cov: 32)
Exomes 𝑓: 0.011 ( 149 hom. )

Consequence

MUSK
NM_005592.4 missense

Scores

2
8
7

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 9.32

Publications

9 publications found
Variant links:
Genes affected
MUSK (HGNC:7525): (muscle associated receptor tyrosine kinase) This gene encodes a muscle-specific tyrosine kinase receptor. The encoded protein may play a role in clustering of the acetylcholine receptor in the postsynaptic neuromuscular junction. Mutations in this gene have been associated with congenital myasthenic syndrome. Alternatively spliced transcript variants have been described.[provided by RefSeq, Oct 2009]
MUSK Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 9
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • fetal akinesia deformation sequence 1
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012486756).
BP6
Variant 9-110800369-A-G is Benign according to our data. Variant chr9-110800369-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 259806.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00809 (1231/152114) while in subpopulation EAS AF = 0.0141 (73/5166). AF 95% confidence interval is 0.0116. There are 13 homozygotes in GnomAd4. There are 554 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 13 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005592.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MUSK
NM_005592.4
MANE Select
c.1991A>Gp.Asn664Ser
missense
Exon 15 of 15NP_005583.1
MUSK
NM_001166280.2
c.1733A>Gp.Asn578Ser
missense
Exon 14 of 14NP_001159752.1
MUSK
NM_001166281.2
c.1703A>Gp.Asn568Ser
missense
Exon 13 of 13NP_001159753.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MUSK
ENST00000374448.9
TSL:5 MANE Select
c.1991A>Gp.Asn664Ser
missense
Exon 15 of 15ENSP00000363571.4
MUSK
ENST00000416899.7
TSL:5
c.1967A>Gp.Asn656Ser
missense
Exon 14 of 14ENSP00000393608.3
MUSK
ENST00000189978.10
TSL:5
c.1733A>Gp.Asn578Ser
missense
Exon 14 of 14ENSP00000189978.6

Frequencies

GnomAD3 genomes
AF:
0.00811
AC:
1232
AN:
151996
Hom.:
13
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00213
Gnomad AMI
AF:
0.0110
Gnomad AMR
AF:
0.00786
Gnomad ASJ
AF:
0.00231
Gnomad EAS
AF:
0.0141
Gnomad SAS
AF:
0.00977
Gnomad FIN
AF:
0.00368
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0123
Gnomad OTH
AF:
0.00288
GnomAD2 exomes
AF:
0.00833
AC:
2076
AN:
249104
AF XY:
0.00867
show subpopulations
Gnomad AFR exome
AF:
0.00123
Gnomad AMR exome
AF:
0.00446
Gnomad ASJ exome
AF:
0.00278
Gnomad EAS exome
AF:
0.00178
Gnomad FIN exome
AF:
0.00418
Gnomad NFE exome
AF:
0.0125
Gnomad OTH exome
AF:
0.00860
GnomAD4 exome
AF:
0.0113
AC:
16491
AN:
1461706
Hom.:
149
Cov.:
32
AF XY:
0.0112
AC XY:
8165
AN XY:
727134
show subpopulations
African (AFR)
AF:
0.00149
AC:
50
AN:
33480
American (AMR)
AF:
0.00429
AC:
192
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00237
AC:
62
AN:
26134
East Asian (EAS)
AF:
0.0280
AC:
1113
AN:
39700
South Asian (SAS)
AF:
0.00924
AC:
797
AN:
86258
European-Finnish (FIN)
AF:
0.00489
AC:
261
AN:
53402
Middle Eastern (MID)
AF:
0.00451
AC:
26
AN:
5768
European-Non Finnish (NFE)
AF:
0.0121
AC:
13427
AN:
1111866
Other (OTH)
AF:
0.00933
AC:
563
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
938
1876
2815
3753
4691
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
482
964
1446
1928
2410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00809
AC:
1231
AN:
152114
Hom.:
13
Cov.:
32
AF XY:
0.00745
AC XY:
554
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.00212
AC:
88
AN:
41504
American (AMR)
AF:
0.00785
AC:
120
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00231
AC:
8
AN:
3466
East Asian (EAS)
AF:
0.0141
AC:
73
AN:
5166
South Asian (SAS)
AF:
0.00957
AC:
46
AN:
4806
European-Finnish (FIN)
AF:
0.00368
AC:
39
AN:
10600
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0123
AC:
836
AN:
67976
Other (OTH)
AF:
0.00285
AC:
6
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
62
125
187
250
312
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00987
Hom.:
17
Bravo
AF:
0.00759
TwinsUK
AF:
0.0124
AC:
46
ALSPAC
AF:
0.0143
AC:
55
ESP6500AA
AF:
0.00423
AC:
18
ESP6500EA
AF:
0.0130
AC:
110
ExAC
AF:
0.00858
AC:
1039
Asia WGS
AF:
0.00375
AC:
13
AN:
3478
EpiCase
AF:
0.0106
EpiControl
AF:
0.0119

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jun 29, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Apr 07, 2016
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MUSK: BS1, BS2

Fetal akinesia deformation sequence 1;C4225368:Congenital myasthenic syndrome 9 Benign:2
Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 02, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Congenital myasthenic syndrome 9 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.32
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.45
T
Eigen
Uncertain
0.30
Eigen_PC
Uncertain
0.41
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.98
D
MetaRNN
Benign
0.012
T
MetaSVM
Uncertain
-0.26
T
MutationAssessor
Benign
0.74
N
PhyloP100
9.3
PrimateAI
Uncertain
0.62
T
PROVEAN
Uncertain
-3.5
D
REVEL
Uncertain
0.44
Sift
Benign
0.081
T
Sift4G
Benign
0.077
T
Polyphen
0.47
P
Vest4
0.69
MVP
0.84
MPC
0.54
ClinPred
0.026
T
GERP RS
5.2
Varity_R
0.38
gMVP
0.46
Mutation Taster
=78/22
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55963442; hg19: chr9-113562649; COSMIC: COSV99079049; API